ESPERION THERAPEUTICS, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of December 17, 2024 5.75% Convertible Senior Subordinated Notes due 2030Indenture • December 18th, 2024 • Esperion Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE dated as of December 17, 2024, between ESPERION THERAPEUTICS, INC., a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
